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This daily COVID-19 Health Evidence Summary is to signpost DFID and other UK government 
departments to the latest relevant evidence and discourse on COVID-19 to inform and support 
their response. It is a result of 3 hours of work and is not intended to be a comprehensive summary 
of evidence. 
Global coalition to accelerate COVID-19 clinical research in resource-limited settings 
COVID-19 Clinical Research Coalition | The Lancet | 2 April | Comment 
https://doi.org/10.1016/S0140-6736(20)30798-4 
Of the 332 COVID-19 related clinical trials (as of 24 March 2020), 188 are open for recruitment 
and 146 trials are preparing to recruit. Most of these trials will be in the countries most affected by 
COVID-19 in the past 2 months, with very few clinical trials planned in Africa, south and southeast 
Asia and central and South America. Low numbers of COVID-19 cases in resource-poor settings 
are expected to rise substantially and quickly surge past the capacity of weak healthcare systems 
to manage patients resulting in high direct and indirect mortality. COVID-19 trials need to be large 
and well designed to generate evidence and priority should be given to interventions that reflect 
specific needs of countries and are readily implementable, equitable and affordable. To address 
these challenges, accelerate and facilitate research needed in resource-poor settings, the 
international COVID-19 Clinical Research Coalition comprised of scientists, physicians, funders 
and policy makers, proposes to bring together existing multinational, multidisciplinary expertise 
and clinical trial capacity; synergise with existing initiatives e.g. CEPI; and use existing research 
capabilities to support, promote, and accelerate multicentre trials of the safety, efficacy and 
effectiveness of interventions against COVID-19 in resource-limited settings. With partners, the 
coalition has four goals (1) facilitate rapid and joint protocol reviews by ethics committees and 
national regulatory agencies; (2) facilitate approvals for the importation of study medicines and 
materials through agreed coordinated fast-track mechanisms; (3) ensure standardised and simple 
collection of key data, sufficient for robust analysis of efficacy and safety of the tested interventions; 
and (4) provide a governance framework to share outcomes before publication. 
Why inequality could spread COVID-19 
Ahmed et al. | The Lancet Public Health | 2 April 2020 | Comment 
https://doi.org/10.1016/S2468-2667(20)30085-2 
2 
This Comment calls for scarce resources and funding allocation decisions to aim to reduce 
inequities and not exacerbate them. 
Does one size fit all? Realistic alternatives for COVID-19 response in low-income 
countries 
Glassman, A, Chalkidou, K & Sullivan, R | Center for Global Development | 2 April 2020 | Blog 
https://www.cgdev.org/blog/does-one-size-fit-all-realistic-alternatives-covid-19-response-low-
income-countries#.XoZrHcd8AS0.twitter 
Caution is expressed about the feasibility of lockdowns and isolation in LMICs, and the cost-
effectiveness of putting large-scale resources into upscaled hospital care. Authors propose three 
suggestions to focus on the broader protection of life in the immediate term that are different in 
scale from existing guidance (1) scale up low-tech clean water and handwashing interventions and 
more toilet facilities; (2) protect other essential healthcare services and supply chains; and (3) 
scale up cash transfers to stay home. Consistent with existing guidance authors recommend some 
changes to prioritisation in LMICs (1) protect the health workforce; (2) target tests; (3) use real 
world national and subnational data to inform modelling forecasts; and (4) develop triage protocols 
for ventilation. As LMICs prepare for the COVID-19 wave there is an urgent need for more tailored 
guidance in LMICs and perhaps a different emphasis in spending than in HICs. 
Safeguard research in the time of COVID-19 
Nature Medicine | 2 April 2020 | Editorial 
https://doi.org/10.1038/s41591-020-0852-1 
Many researchers have refocused their work including stepping in to assist the population by 
developing, scaling up and performing diagnostic tests, understanding the biology of the disease, 
testing whether existing drugs can be repurposed to treat patients, developing models to aid in 
understanding  how the pandemic is evolving, how to reduce its impact and how to test the impact 
of non-pharmaceutical interventions. “First responders, doctors, nurses and health professionals 
are at the frontlines of the fight against the virus – but scientists remain at the core of the solution”.  
Government, funders, universities and institutions must support scientists and ensure the healthy 
future of research. 
COVID-19: WHO issues interim guidance for implementation of NTD programmes 
WHO | 1 April 2020 | Interim guidelines 
https://www.who.int/neglected_diseases/news/COVID19-WHO-interim-guidance-implementation-
NTD-programmes/en/ 
Consistent with COVID-19 public health measures, WHO recommends that community-based 
surveys, active case-finding activities and mass treatment campaigns for neglected tropical 
diseases be postponed until further notice. Care for those presenting to healthcare facilities and 
essential vector control measures should continue as normal. WHO encourages local health 
authorities to use existing NTD platforms, surveillance mechanisms and WASH/health education 
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opportunities to support implementation of COVID-19 measures where appropriate. Note that 
these guidelines are interim and more detailed guidance will be issued in due course. 
Quantifying SARS-CoV-2 transmission suggests epidemic control with digital contact 
tracing 
Ferretti L. & Wymant C et al. | Science | 31 March 2020 | Article 
https://doi.org/10.1126/science.abb6936 
This study suggests SARS-CoV-2 transmission could be contained better if contact tracing became 
digital instead of manual due to the speed of viral spread. Intelligent physical distancing via digital 
contact tracing could speed up contact tracing, be more efficient and happen at scale. A contact-
tracing App which builds a memory of proximity contacts and immediately notifies contacts of 
positive cases can achieve epidemic control if used by enough people and recommendations could 
be to only those at risk offering an alternative to mass quarantines. Authors discuss ethical 
requirements for such an intervention. 
WHO urges countries to ensure the continuity of malaria services in the context of the 
COVID-19 pandemic: Safety of front-line health workers a primary concern 
WHO | 25 March | News 
https://www.who.int/news-room/detail/25-03-2020-who-urges-countries-to-ensure-the-continuity-
of-malaria-services-in-the-context-of-the-covid-19-pandemic 
WHO underlines the importance of sustaining and not scaling back efforts to prevent, detect and 
treat malaria. Continuing access to core malaria prevention measures (vector control and 
chemoprevention for pregnant women and young children) is an important strategy for reducing 
the strain on health systems. WHO will provide guidance for countries to safely maintain essential 
health services in the context of the COVID-19 response. 
Tracking COVID-19 cases 
Global 
WHO COVID-19 daily situation reports 
https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports 
An interactive web-based dashboard to track COVID-19 in real time 
https://gisanddata.maps.arcgis.com/apps/opsdashboard/index.html#/bda7594740fd40299423467
b48e9ecf6 
Live data tracker: sex-disaggregated COVID-19 data from the 25 most-affected countries 
http://globalhealth5050.org/covid19 
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Africa 
Coronavirus in Africa Tracker: How many covid-19 cases & where? 
https://africanarguments.org/2020/03/23/coronavirus-in-africa-tracker-how-many-cases-and-
where-latest/ 
UK 
COVID-19: PHE track coronavirus cases in the UK 
https://www.gov.uk/government/publications/covid-19-track-coronavirus-cases 
UK case tracing infographic 
https://www.arcgis.com/apps/opsdashboard/index.html#/f94c3c90da5b4e9f9a0b19484dd4bb14 
Online learning  
COVID-19 and Disability 
ARISE | Monday 6 April 1100-1230 BST | Twitter chat 
http://www.ariseconsortium.org/disability-and-covid-19-twitter-chat-disabilityc19/ 
Use the hashtag #DisabilityC19 to join in. 
Responding to COVID-19: Real-time training for the coronavirus disease outbreak 
WHO | Available now | multiple self-paced courses 
https://openwho.org/channels/covid-19 
Note that courses are available in English and other languages including French, Portuguese 
and Spanish. 
COVID-19: Tackling the Novel Coronavirus 
LSHTM | FutureLearn course | Starts 23 March 2020 | 3 weeks | 4 hours weekly study | Free 
https://www.futurelearn.com/courses/covid19-novel-coronavirus 
A reminder that this course is currently running. On this course you will learn what is known 
about the outbreak of COVID-19 (week 1); what the practical implications for responding to 
COVID-19 are (week 2); and what we need to find out about COVID-19 (week 3). 
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Resource Hubs 
COVID-19 Research Project Tracker by UKCDR & GloPID-R 
https://www.ukcdr.org.uk/funding-landscape/covid-19-research-project-tracker/ 
A live database of funded research projects across the world related to COVID-19 mapped against 
the priorities identified in the WHO Coordination Global Research Roadmap: 2019 Novel 
Coronavirus. 
WHO Q&A on COVID-19 
https://www.who.int/news-room/q-a-detail/q-a-coronaviruses 
Note that this resource includes Q&A on COVID-19; COVID-19, pregnancy, childbirth and 
breastfeeding; COVID-19, HIV and antiretrovirals; similarities and differences COVID-19 and 
influenza; mass gatherings and COVID-19; IPC for healthcare workers; COVID-19 and food and 
agriculture; smoking and COVID-19; malaria and COVID-19. 
COVID-19: Resources and research on epidemics and pandemics 
https://steps-centre.org/covid-19-coronavirus-resources-research-epidemics-pandemics/ 
Stop TB Partnership TB and COVID-19 
http://www.stoptb.org/covid19.asp 
EPI-WIN: WHO information network for epidemics: COVID-19 public health emergency 
https://www.who.int/teams/risk-communication 
COVID-19: Research ethics 
https://ethicsresource.ringsgenderresearch.org/covid-19-resources/ 
LSTM: COVID-19 
https://www.lstmed.ac.uk/covid-19 
LSHTM: COVID-19 
https://www.lshtm.ac.uk/research/research-action/covid-19 
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International Disability Alliance: COVID 19 and the disability movement 
http://www.internationaldisabilityalliance.org/content/covid-19-and-disability-movement 
Africa Centres for Disease Control and Prevention (Africa CDC) 
https://africacdc.org/covid-19/ 
UNICEF: Latest news and updates on coronavirus disease 2019 (COVID-19) 
https://www.unicef.org/coronavirus/covid-19 
Coronavirus: the science explained 
https://coronavirusexplained.ukri.org/en/ 
Social Science in Humanitarian Action: Updates on the novel COVID-19 outbreak 
https://www.socialscienceinaction.org/update-novel-covid-19-outbreak/ 
Special Collection: Coronavirus (COVID-19): evidence relevant to critical care 
https://www.cochrane.org/news/special-collection-coronavirus-covid-19-evidence-relevant-
critical-care 
NICE UK: Rapid guidelines and evidence reviews  
https://www.nice.org.uk/covid-19 
Imperial College London MRC Centre for Global Infectious Disease Analysis COVID-19 
reports 
https://www.imperial.ac.uk/mrc-global-infectious-disease-analysis/news--wuhan-coronavirus/ 
Global research on COVID-19 
https://www.who.int/emergencies/diseases/novel-coronavirus-2019/global-research-on-novel-
coronavirus-2019-ncov 
WHO R&D Blueprint 
https://www.who.int/blueprint/priority-diseases/key-action/novel-coronavirus/en/ 
WHO: Coronavirus disease (COVID-19) outbreak resources 
https://www.who.int/emergencies/diseases/novel-coronavirus-2019 
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Latest information and advice from the UK Government 
https://www.gov.uk/guidance/coronavirus-covid-19-information-for-the-public 
CDC COVID-19 Resources 
https://www.cdc.gov/coronavirus/2019-ncov/index.htmlThe Global Health Network Coronavirus 
outbreak knowledge hub 
The Lancet COVID-19 Resource Centre 
https://www.thelancet.com/coronavirus 
Elsevier’s Novel Coronavirus Information Center 
https://www.elsevier.com/connect/coronavirus-information-center 
Cell Press Coronavirus Resource Hub 
https://www.cell.com/2019-nCOV 
Cochrane Special Collections - COVID-19: infection control and prevention measures 
https://www.cochranelibrary.com/collections/doi/SC000040/full 
The BMJ Coronavirus (covid-19): Latest news and resources 
https://www.bmj.com/coronavirus?int_source=wisepops&int_medium=wisepops&int_campaign=
DAA_CoronaVirus_Jan24 
Johns Hopkins Coronavirus Resource Centre 
https://coronavirus.jhu.edu 
Global Partnership for Sustainable Development – COVID-19 resources 
http://www.data4sdgs.org/resources/covid-19-resources 
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About this report 
This daily COVID-19 health evidence summary is based on 3 hours of desk-based research. K4D services are 
provided by a consortium of leading organisations working in international development, led by the Institute of 
Development Studies (IDS), with Education Development Trust, Itad, University of Leeds Nuffield Centre for 
International Health and Development, Liverpool School of Tropical Medicine (LSTM), University of Birmingham 
International Development Department (IDD) and the University of Manchester Humanitarian and Conflict 
Response Institute (HCRI). 
This evidence summary was prepared for the UK Government’s Department for International 
Development (DFID) and its partners in support of pro-poor programmes. It is licensed for non-
commercial purposes only. K4D cannot be held responsible for errors, omissions or any 
consequences arising from the use of information contained in this health evidence summary. 
Any views and opinions expressed do not necessarily reflect those of DFID, K4D or any other 
contributing organisation.  
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